Report Detail
Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4750721 |
- 05 October, 2026 |
- Global |
- 98 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Porcine circovirus (PCV) and Mycoplasma hyopneumoniae (MHP) vaccine is a vaccine used to prevent important swine diseases such as porcine circovirus (PCV) and mycoplasma swine pneumonia (MHP). This vaccine combines immune protection against two major diseases and is designed to improve the health and production performance of porcine herds.
This report is a detailed and comprehensive analysis for global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Zoetis, Merck, Pharmgate, Ceva, Huizhong Biological, Jiangsu Nannong Hi-Tech, SPAH, Jinyu Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
One-dose Type
Two-dose Type
Market segment by Application
Piglet
Adult Pig
Major players covered
Boehringer Ingelheim
Zoetis
Merck
Pharmgate
Ceva
Huizhong Biological
Jiangsu Nannong Hi-Tech
SPAH
Jinyu Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine, with price, sales quantity, revenue, and global market share of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine from 2021 to 2026.
Chapter 3, the Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine.
Chapter 14 and 15, to describe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 One-dose Type
- 1.3.3 Two-dose Type
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Piglet
- 1.4.3 Adult Pig
- 1.5 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size & Forecast
- 1.5.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity (2021-2032)
- 1.5.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Boehringer Ingelheim
- 2.1.1 Boehringer Ingelheim Details
- 2.1.2 Boehringer Ingelheim Major Business
- 2.1.3 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.1.4 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Boehringer Ingelheim Recent Developments/Updates
- 2.2 Zoetis
- 2.2.1 Zoetis Details
- 2.2.2 Zoetis Major Business
- 2.2.3 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.2.4 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Zoetis Recent Developments/Updates
- 2.3 Merck
- 2.3.1 Merck Details
- 2.3.2 Merck Major Business
- 2.3.3 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.3.4 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Merck Recent Developments/Updates
- 2.4 Pharmgate
- 2.4.1 Pharmgate Details
- 2.4.2 Pharmgate Major Business
- 2.4.3 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.4.4 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Pharmgate Recent Developments/Updates
- 2.5 Ceva
- 2.5.1 Ceva Details
- 2.5.2 Ceva Major Business
- 2.5.3 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.5.4 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ceva Recent Developments/Updates
- 2.6 Huizhong Biological
- 2.6.1 Huizhong Biological Details
- 2.6.2 Huizhong Biological Major Business
- 2.6.3 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.6.4 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Huizhong Biological Recent Developments/Updates
- 2.7 Jiangsu Nannong Hi-Tech
- 2.7.1 Jiangsu Nannong Hi-Tech Details
- 2.7.2 Jiangsu Nannong Hi-Tech Major Business
- 2.7.3 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.7.4 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Jiangsu Nannong Hi-Tech Recent Developments/Updates
- 2.8 SPAH
- 2.8.1 SPAH Details
- 2.8.2 SPAH Major Business
- 2.8.3 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.8.4 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 SPAH Recent Developments/Updates
- 2.9 Jinyu Biotechnology
- 2.9.1 Jinyu Biotechnology Details
- 2.9.2 Jinyu Biotechnology Major Business
- 2.9.3 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product and Services
- 2.9.4 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Jinyu Biotechnology Recent Developments/Updates
3 Competitive Environment: Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine by Manufacturer
- 3.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturer (2021-2026)
- 3.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturer Market Share in 2025
- 3.5 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market: Region Footprint
- 3.5.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market: Company Product Type Footprint
- 3.5.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Region
- 4.1.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Region (2021-2032)
- 4.1.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price by Region (2021-2032)
- 4.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021-2032)
- 4.3 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021-2032)
- 4.4 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021-2032)
- 4.5 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021-2032)
- 4.6 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 5.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Type (2021-2032)
- 5.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 6.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Application (2021-2032)
- 6.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price by Application (2021-2032)
7 North America
- 7.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 7.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 7.3 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
- 7.3.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 8.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 8.3 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
- 8.3.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 10.2 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 10.3 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
- 10.3.1 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Drivers
- 12.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Restraints
- 12.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine
- 13.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Typical Distributors
- 14.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine. Industry analysis & Market Report on Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is a syndicated market report, published as Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
